RALEIGH, N.C., Oct. 6, 2023 /PRNewswire/ — Contego Medical Inc., a company dedicated to improving patient outcomes and procedural efficiency in the treatment of carotid and peripheral vascular disease, today announced enrollment of the first patient in the PERFORMANCE III Trial. PERFORMANCE […]
Tag: Contego Medical
Contego Medical Completes Enrollment of the PERFORMANCE II Carotid Stent Trial
RALEIGH, N.C., Nov. 14, 2022 /PRNewswire/ — Contego Medical, Inc. announced that enrollment of the PERFORMANCE II clinical trial has been completed. PERFORMANCE II is designed to evaluate the safety and effectiveness of the Neuroguard IEP® 3-in-1 Carotid Stent and Post-Dilation Balloon […]
Contego Medical Announces Hiring of Steve MacKinnon, Chief Commercialization Officer
RALEIGH, N.C., Feb. 10, 2022 /PRNewswire/ — Contego Medical has announced that Steve MacKinnon has joined the organization as their Chief Commercialization Officer. Mr. MacKinnon is an accomplished senior medical device executive with significant commercialization experience, a track record of success, and a history of […]
Contego Medical Receives CE Mark Approval for Next Generation Carotid Stent
RALEIGH, N.C., April 16, 2021 /PRNewswire/ — Contego Medical, Inc., a leading developer of innovative cardiovascular devices, today announced receipt of CE Mark approval for the Neuroguard IEP® 3-in-1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection (Neuroguard IEP System). The patented […]
Contego Medical Announces the Start of Enrollment in the PERFORMANCE II Carotid Stenting Clinical Trial
RALEIGH, N.C., June 15, 2020 /PRNewswire/ — Contego Medical, Inc. today announced enrollment of the first patient in the PERFORMANCE II Trial evaluating the safety and effectiveness of the Neuroguard IEP® 3 in 1 Carotid Stent and Post-Dilation Balloon System with Integrated […]